These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 19918175

  • 1. Microbicides and HIV prevention: lessons from the past, looking to the future.
    Morris GC, Lacey CJ.
    Curr Opin Infect Dis; 2010 Feb; 23(1):57-63. PubMed ID: 19918175
    [Abstract] [Full Text] [Related]

  • 2. Microbicides for HIV prevention: reality or hope?
    McGowan I.
    Curr Opin Infect Dis; 2010 Feb; 23(1):26-31. PubMed ID: 19935418
    [Abstract] [Full Text] [Related]

  • 3. Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ, Uckun FM.
    Curr Pharm Des; 2004 Feb; 10(3):315-36. PubMed ID: 14754390
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Women's interest in vaginal microbicides.
    Darroch JE, Frost JJ.
    Fam Plann Perspect; 1999 Feb; 31(1):16-23. PubMed ID: 10029928
    [Abstract] [Full Text] [Related]

  • 7. Microbicide research: current and future directions.
    Ramjee G.
    Curr Opin HIV AIDS; 2010 Jul; 5(4):316-21. PubMed ID: 20543607
    [Abstract] [Full Text] [Related]

  • 8. Microbicides for the prevention of HIV infection in women: an overview of recent trials.
    Rosenberg ZF, Nel A, Heyward W, Mitchnick M.
    Curr Opin HIV AIDS; 2006 Nov; 1(6):514-9. PubMed ID: 19372855
    [Abstract] [Full Text] [Related]

  • 9. Microbicide acceptability research: current approaches and future directions.
    Mantell JE, Myer L, Carballo-Diéguez A, Stein Z, Ramjee G, Morar NS, Harrison PF.
    Soc Sci Med; 2005 Jan; 60(2):319-30. PubMed ID: 15522488
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The future of HIV prevention: prospects for an effective anti-HIV microbicide.
    Nuttall J, Romano J, Douville K, Galbreath C, Nel A, Heyward W, Mitchnick M, Walker S, Rosenberg Z.
    Infect Dis Clin North Am; 2007 Mar; 21(1):219-39, x. PubMed ID: 17502237
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Past, present, and future of entry inhibitors as HIV microbicides.
    Gibson RM, Arts EJ.
    Curr HIV Res; 2012 Jan 01; 10(1):19-26. PubMed ID: 22264042
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
    Whaley KJ, Hanes J, Shattock R, Cone RA, Friend DR.
    Antiviral Res; 2010 Dec 01; 88 Suppl 1():S55-66. PubMed ID: 21109069
    [Abstract] [Full Text] [Related]

  • 18. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 01; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 19. Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission.
    Klasse PJ, Shattock R, Moore JP.
    Annu Rev Med; 2008 Dec 01; 59():455-71. PubMed ID: 17892435
    [Abstract] [Full Text] [Related]

  • 20. Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets.
    Garg S, Goldman D, Krumme M, Rohan LC, Smoot S, Friend DR.
    Antiviral Res; 2010 Dec 01; 88 Suppl 1():S19-29. PubMed ID: 21109064
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.